Growth differentiation factor promoter and uses therefor

Details Growth differentiation factor promoter and uses therefor Growth differentiation factor promoter and uses therefor

1999-07-15

2003-04-29

Crouch, Deborah (Department: 1632)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023100, C435S235100, C435S325000

Reexamination Certificate

active

06555672

ABSTRACT:

FIELD OF THE INVENTION
The invention relates to GDF promoters, such as GDF-8 promoters, as well as methods of using them, e.g., methods for screening for regulatory compounds of GDF-8 expression.
BACKGROUND OF THE INVENTION
GDF-8 is a member of the TGF-&bgr; superfamily, which encompasses a large group of growth and differentiation factors that play important roles in regulating embryonic development and in maintaining tissue homeostasis in adult mammals. GDF-8 appears to function specifically as a negative regulator of skeletal muscle growth and, therefore, has potential applications in producing livestock and game animals, such as cows, sheep, pigs, chicken, turkey, and fish which are relatively high in musculature and protein, and low in fat content. In addition, GDF-8 has potential applications in various cell proliferative and differentiation disorders, especially those involving muscle, nerve and adipose tissues in both human and animals. GDF-8 also appears to be involved in glucose transport and, therefore, has potential applications in the treatment or diagnosis of glucose transport associated disorders such as diabetes.
Many drug and diet regimens exist which may help increase muscle and protein content and lower undesirably high fat and/or cholesterol levels, but such treatment is generally administered after the fact, and is begun only after significant damage has occurred to the vasculature. Accordingly, it would be desirable to produce animals which are genetically predisposed to having higher muscle content, without any ancillary increase in fat levels. U.S. patent application Ser. No. 09/019,070, inventors Se-Jin Lee and Alexandra C. McPherron, filed Feb. 5, 1998 and entitled Growth Differentiation Factor-8 also describes the production of GDF-8, as well as potential uses. This application is also hereby incorporated by reference.
Control of GDF-8 gene expression is highly desirable. The availability of discreet DNA segments which are capable of conferring either a negative or positive control capability to known genes in eukaryotic systems is generally lacking in the art. Isolation of regulatory genetic sequences for GDF-8 is disclosed in the present invention.
SUMMARY OF THE INVENTION
The present invention relates to the molecular regulation of GDF-8 expression and, in particular, to the isolation and identification of regulatory sequences of GDF gene promoters, such as the GDF-8 gene promoter.
In one embodiment, the present invention provides the complete nucleotide sequence and identification of genetic regulatory elements which promote expression of GDF-8.
In another embodiment, the present invention provides a method of screening for compounds which regulate GDF-8 expression, for example, by inhibiting or by stimulating GDF-8 expression.
In yet another embodiment, the present invention provides a DNA expression construct containing the GDF-8 promoter operatively linked to a gene of interest (GOI), and a method of expressing a GOI in muscle and other tissues (e.g., tissues in which GDF-8 is naturally expressed).


REFERENCES:
Mullins et al. J Clin. Invest. 98(11): S37-40, 1996.*
Palmiter et al. Ann Rev. Genet. 20: 465-99, 1986.*
Cameron, ER. Molecular Biotechnology. 7: 253-265, 1997.*
Eck et al. “Gene Based Therapy” Chap 5, Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th Ed. pp. 77-101, 1995.*
Verma et al. Nature. 389: 239-242, Sep. 1997.*
Miller et al. FASEB J. 9: 190-199, Feb. 1995.*
Deonarain, MP. Exp. Opin. Ther. Patents. 8(1): 53-69, 1998.*
Crystal R.G. Science. 270: 404-410, 1995.*
McPherron et al. J Biol. Chem. 268(5): 3444-9, Feb. 1993.*
GenCore Accession No. AF093798, Daneau et al., Oct. 1998.*
GenCore Accession No. X24464, Georges et al., Jun. 1999.*
Dickman S. Gene mutation provides more meat on the hoof. Science. Sep. 26, 1997;277(5334):1922-3.
GenBank Accession No. AJ133580 for Sus scrofa partial myostatin gene.
GenBank Accession No. AF093798 for Sus Scrofa myostatin (gdf8) gene.
Gonzalez-Cadavid NF, et al., Organization of the human myostatin gene and expression in healthy mean and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A. Dec. 8, 1998;95(25):14938-43.
Grobet L, et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet. Sep. 1997;17(1):71-4.
Grobet L, et al. Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle. Mann Genome. Mar. 1998;9(3):210-3.
Ji S, et al. Myostatin expression in porcine tissues: tissue specificity and developmental and postnatal regulation. Am J Physiol. Oct. 1998;275(4 Pt 2):R1265-73.
Kambadur R, et al. Mutations in myostatin (GDF8) in double-muscle Belgian Blue and Piedmontese cattle. Genome Res. Sep. 1997;7(9):910-6.
McPherron AC, et al. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. May 1, 1997;387(6628):83-90.
McPherron AC, et al. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A. Nov. 11, 1997;94(23):12457-61.
Murch SH, et al. Nutrition in inflammatory bowel disease. Baillieres Clin Gastroenterol. Dec. 1998:12(4):719-38.
Slack JM. Growth control: action mouse. Curr Biol. Aug. 1, 1997;7(8):R467-9.
Smith TP, et al. Myostatin maps to the interval containing the bovine mh locus. Mamm Genome. Oct. 1997;8(10):742-4.
Sonstegard TS, et al. Refinement of bovine chromosome 2 linkage map near the mh locus reveals rearrangements between the bovine and human genomes. Anim Genet. Oct. 1998;29(5):341-7.
Sonstegard TS, et al. Myostatin maps to porcine chromosome 15 by linkage and physical analyses. Anim Genet. Feb. 1998;29(1):19-22.
Szabo G, et al. A deletion in the myostatin gene causes the compact (Cmpt) hypermuscular mutation in mice. Mamm Genome. Aug. 1998;9(8):671-2.
Westhusin M. From mighty mice to mighty cows. Nat Genet. Sep. 1997;17(1):4-5.

Affiliated with

Also associated with

Rating

Growth differentiation factor promoter and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Growth differentiation factor promoter and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth differentiation factor promoter and uses therefor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3097791